The Board of Directors of Sopharma AD (the “Company”) announces that it took a decision to sell 8976 ordinary registered shares with voting rights, representing 51% of the capital of ZAO "Rostbalkanpharm", city of Azov, Rostov region, Russian Federation, divided into 17,600 common shares of emission with state registration № 1-01-58454-P.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from April 12 2012 up to and including April 18 2012 the Company bought 1000 own shares representing 0.000757% of the share capital of the Company, to the total value of BGN 2642.00 on the Bulgarian Stock Exchange. The average price per share was 2.64 BGN.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

SOPHARMA AD (the “Company”) hereby informs that from 11 July 2013 up to and including 17 July 2013 the Company bought 31378 own shares representing 0.024% of the share capital of the Company, to the total value of BGN 96443.15 on the Bulgarian Stock Exchange. The average price per share was BGN 3.07.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 4476884, representing 3.39% of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 18 July 2013 up to and including 24 July 2013 the Company bought 161424 own shares representing 0.12% of the share capital of the Company, to the total value of BGN 528930.57 on the Bulgarian Stock Exchange. The average price per share was BGN 3.277.

The shares have been bought on the basis of the general meeting resolution No. 7 of 23.06.2010.

The total number of own shares after these transactions is 4638308, representing 3.51% of the share capital of the Company.

Sopharma AD (the “Company”) announces that on 11 February 2014 the Company received a notification for the sale of 3 424 005 shares by UPF Doverie. After the transaction the share of UPF Doverie in the capital of Sopharma AD decreased to 4,155 %.

The registration date of the transaction in the Central Depository AD, Sofia is 6 February 2014.

The Board of Directors of SOPHARMA AD (the “Company”) hereby informs that from 19 April 2012 up to and including 24 April 2012 the Company bought 200 own shares representing 0.00015% of the share capital of the Company, to the total value of 521 BGN on the Bulgarian Stock Exchange. The average price per share was 2.61 BGN.

The shares have been bought on the basis of the general meeting resolution of 23.06.2010.

The intention of the Company is to use the repurchased shares in the future for the purpose of providing them to shareholders of companies targeted in mergers.

SOPHARMA AD (the “Company”) hereby informs that from 6 February 2014 up to and including 12 February 2014 the Company bought 9 990 own shares representing 0.0076% of the share capital of the Company, to the total value of 42 882.50 BGN on the Bulgarian Stock Exchange, the average price per share was 4.29 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 027 873, representing 3.81% of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 13 February 2014 up to and including 19 February 2014 the Company bought 1 500 own shares representing 0.0011% of the share capital of the Company, to the total value of 6 420.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.28 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 029 373, representing 3.81% of the share capital of the Company.

SOPHARMA AD (the “Company”) hereby informs that from 20 February 2014 up to and including 26 February 2014 the Company sold 10 111 own shares representing 0.0077% of the share capital of the Company, to the total value of 44 764.85 BGN on the Bulgarian Stock Exchange, the average price per share was 4.43 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 019 262, representing 3.80% of the share capital of the Company.

Sopharma AD (the “Company”) announces that: Sopharma AD bought 1000 shares, representing 0.21% of the capital of Maritzatex AD and as a result of this transaction the Company has crossed the threshold of 10 % of the capital of Maritzatex AD and now owns 10.12% of the capital of the latter.

The date of registration of the transaction with the Central Depository is 31 July 2013.